课题基金 / 基金详情

项目摘要

项目成果

Jennifer Rubin Grandis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We established the UCSF Clinical and Translational Science Institute (CTSI) at the University of California, San Francisco (UCSF) in 2006 to accelerate the pace of research that improves the health ofthe public. The overall mission of CTSI has been to improve and transform clinical and translational research infrastructure and training at UCSF and our partner institutions. In the next funding period we aim to use the substantial knowledge, skills, and infrastructure that we have developed to further accelerate the pace of research at UCSF, to export our successes to other institutions, and to create initiatives aimed at improving the health of our own and other communities, through the following aims: SPECIFIC AIM 1: To enhance the highly successful activities of the UCSF CTSI, including the development of new initiatives in the areas of Training, Jnfrastructure/Services, and Advocacy/Culture Change: a) Training: to provide programs for students at all levels, across a spectrum of settings, and including all phases of the improvement of healthcare; b) Infrastructure/Services: to expand services and tools to clinical and translational investigators at UCSF, our partner institutions, and within the broader regional, national, and global communities; and, c) Advocacy/Culture Change: to nurture communication, encourage collaboration, foster innovation, and catalyze the successful conduct of clinical and translational research; to support a diverse faculty; to increase involvement ofthe community and the responsive of research to its needs; and change the academic culture to promote multidisciplinary, collaborative work. SPECIFIC AIM 2: To develop crosscutting initiatives using the knowledge, skills, and infrastructure developed by multiple CTSI programs in the first funding period to accelerate clinical and translational research and its impact on health, well beyond the institutions collaborating in the UCSF CTSI. New initiatives will: a) Bring together local public health and philanthropic groups to work with CTSI to improve the health of the San Francisco Bay Area community through a series of health improvement projects directed at high impact conditions; b) create a model system to accelerate the pace of clinical and translational research that includes streamlining regulation, developing participant recruitment services, providing research management, and bringing research services directly into community practices; and, c) improve the performance, transparency and accountability of research administration within and jeyond CTSI by setting challenging goals and tracking performance metrics on public dashboards. These aims will be achieved by orchestration of activities occurring within and between our 10 programs, supported by a proven governance model, and with strong ties to institutional and community leadership. Our ultimate goal is to bring better health to more people more quickly.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/pace.12962
发表时间: 2016-12
期刊: Pacing and clinical electrophysiology : PACE
影响因子: --
作者: [Nguyen KT, Gladstone RA, Dukes JW, Nazer B, Vittinghoff E, Badhwar N, Vedantham V, Gerstenfeld EP, Lee BK, Lee RJ, Tseng ZH, Olgin JE, Scheinman MM, Marcus GM]
通讯作者: Marcus GM
DOI: 10.1097/ta.0000000000001313
发表时间: 2017-02
期刊: The journal of trauma and acute care surgery
影响因子: --
作者: [Kunitake RC, Howard BM, Kornblith LZ, Christie SA, Conroy AS, Cohen MJ, Callcut RA]
通讯作者: Callcut RA
DOI: 10.1136/tsaco-2017-000131
发表时间: 2018
期刊: Trauma surgery & acute care open
影响因子: 2
作者: [Kunitake RC, Kornblith LZ, Cohen MJ, Callcut RA]
通讯作者: Callcut RA
Increasing Rates of Surgical Management of Multilevel Spinal Curvature in Elderly Patients.
老年患者多级脊柱弯曲的手术治疗率不断提高。
DOI: 10.1016/j.jspd.2016.03.005
发表时间: 2016
期刊: Spine deformity
影响因子: 1.6
作者: [Sing,DavidC, Khanna,Ryan, Shaw,JeremyD, Metz,LionelN, Burch,Shane, Berven,SigurdH]
通讯作者: Berven,SigurdH
7
    Targeting STAT3 to enhance anti-tumor immunity
    Targeting STAT3 to enhance anti-tumor immunity
    Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
    Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
    海外基金